Prot# 20030236: A Phase 4, Open-Label, Single-Arm, Observational Study Evaluating The Effectiveness and Safety of Enbrel® (etanercept) 50mg Once Weekly in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (infliximab)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/9/04 → 9/10/10

Funding

  • Amgen, Inc. (20030236)